|
ITTF
Handbook 2009
/ 2010 |
| Index |
Description |
| 5.04 |
THE PROHIBITED LIST |
| 5.04.01 |
Incorporation of the Prohibited List
These Anti-Doping Rules incorporate the Prohibited List which is published and revised by WADA as described in Article 4.1 of the Code. ITTF will make the current Prohibited List available to each National Association, and each National Association shall ensure that the current Prohibited List is available to its members and constituents.
|
| 5.04.02 |
Prohibited Substances and Prohibited Methods Identified on the Prohibited List |
| 5.04.02.01 |
Prohibited Substances and Prohibited Methods Identified on the Prohibited List
Unless provided otherwise in the Prohibited List and/or a revision, the Prohibited List and revisions shall go into effect under these Anti-Doping Rules three months after publication of the Prohibited List by WADA without requiring any further action by ITTF. As described in Article 4.2 of the Code, ITTF may request that WADA expand the Prohibited List. As provided in the Code, WADA shall make the final decision on such requests by ITTF. |
| 5.04.02.02 |
Specified Substances
For purposes of the application of Article 5.10 (Sanctions on Individuals), all Prohibited Substances shall be gSpecified Substancesh except (a) substances in the classes of anabolic agents and hormones; and (b) those stimulants and hormone antagonists and modulators so identified on the Prohibited List. Prohibited Methods shall not be Specified Substances.
|
| 5.04.02.03 |
New Classes of Prohibited Substances
In the event WADA expands the Prohibited List by adding a new class of Prohibited Substances in accordance with Article 4.1 of the Code, WADAfs Executive Committee shall determine whether any or all Prohibited Substances within the new class of Prohibited Substances shall be considered Specified Substances under Article 5.4.2.2.
|
| 5.04.03 |
Criteria for Including Substances and Methods on the Prohibited List
As provided in Article 4.3.3 of the Code, WADAfs determination of the Prohibited Substances and Prohibited Methods that will be included on the Prohibited List and the classification of substances into categories on theProhibited List is final and shall not be subject to challenge by an Athlete or other Person based on an argument that the substance or method was not a masking agent or did not have the potential to enhance performance, represent a health risk or violate the spirit of sport. |
| 5.04.04 |
Therapeutic Use |
| 5.04.04.01 |
Athletes with a documented medical condition requiring the use of a Prohibited Substance or a Prohibited Method must first obtain a TUE. The presence of a Prohibited Substance or its Metabolites or Markers (Article 5.2.1), Use or Attempted Use of a Prohibited Substance or a Prohibited Method (Article 5.2.2), Possession of Prohibited Substances or Prohibited Methods (Article 5.2.6) or administration of a Prohibited Substance or Prohibited Method (Article 5.2.8) consistent with the provisions of an applicable TUE issued pursuant to the International Standard for Therapeutic Use Exemptions shall not be considered an anti-doping rule violation. |
| 5.04.04.02 |
Subject to Article 5.4.4.3, Athletes included by the ITTF in its Registered Testing Pool and other Athletes participating in any International Event must obtain a TUE from the ITTF (regardless of whether the Athlete previously has received a TUE at the national level). The application for a TUE must be made as soon as possible (in the case of an Athlete in the Registered Testing Pool, this would be when he/she is first notified of his/her inclusion in the pool) and in any event (save in emergency situations) no later than 21 days before the Athletefs participation in the Event. |
| 5.04.04.03 |
The only exception to Article 5.4.4.2 is that, in accordance with Article 7.13 of the International Standard for Therapeutic Use Exemptions, Athletes not in the ITTF’s Registered Testing Pool who inhale Glucocorticosteroids and/or formoterol, salbutamol, salmeterol or terbutaline to treat asthma or one of its clinical variants do not need a TUE in advance of participating in an International Event unless so specified by the ITTF. Instead, if necessary, any such Athlete may apply for a Retroactive TUE after the Event in accordance with Article 7.13 of the International Standard for Therapeutic Use Exemptions and Article 5.7.1.3¬ of these Anti-Doping Rules. |
| 5.04.04.03.01 |
International-Level Athletes who are included in the ITTF's Registered Testing Pool, should apply to ITTF for the TUE at the same time the Athlete first provides whereabouts information to the ITTF and, except in emergency situations, no later than 21 days before the Athlete's participation at an International Event. |
| 5.04.04.03.02 |
Athletes participating in International Events who are not included in the ITTF Registered Testing Pool must, except in emergency situations, request a TUE from ITTF no later than 21 days before the Athlete's participation at an International Event. |
| 5.04.04.04 |
TUE's granted by the ITTF shall be reported to the Athlete's National Association and to WADA. Other Athletes subject to Testing who need to use a Prohibited Substance or a Prohibited Method for therapeutic reasons must obtain a TUE from their National Anti-Doping Organization or other body designated by their National Association, as required under the rules of the National Anti-Doping Organization/other body. National Associations shall promptly report any such TUEfs to the ITTF and WADA. |
| 5.04.04.05 |
The ITTF Executive Committee shall appoint a panel of physicians to consider requests for TUEfs (the ). Upon the ITTF's receipt of a TUE request, the Chair of the TUE Panel shall appoint one or more members of the TUE Panel (which may include the Chair) to consider such request. The TUE Panel member(s) so designated shall promptly evaluate such request in accordance with the International Standard for Therapeutic Use Exemptions and render a decision on such request, which shall be the final decision of the ITTF |
| 5.04.04.06 |
WADA, at the request of an Athlete or on its own initiation, may review the granting or denial of any TUE by the ITTF. If WADA determines that the granting or denial of a TUE did not comply with the International Standard for Therapeutic Use Exemptions in force at the time then WADA may reverse that decision. Decisions on TUEfs are subject to further appeal as provided in Article 5.13. |